Monday, October 3, 2022


Biotechnology News Magazine

Abraham Verghese MD Appointed to the Board of Directors of Athos Therapeutics

Noted Stanford Physician and Recipient of the National Humanities Medal at the White House from former President Obama

Latest Posts

City of Hope to Accelerate Immunotherapy Research & Treatment Innovation with $15 Mil Gift from Ted Schwartz Family

Ted Schwartz, who is now cancer free, achieved complete remission at City of Hope in 2020 with the center's leading CAR T cell therapy after a 16-year battle with lymphoma, provided the gift to City of Hope to advance treatment options that offer better outcomes and quality of life for people living with cancer.

Neurocrine Biosciences Appoints Dr Ingrid Delaet as Chief Regulatory Officer

Prior to joining Neurocrine Biosciences, Dr Ingrid Delaet served as Senior Vice President, Regulatory Affairs at Intercept Pharmaceuticals, which she joined in 2016.

Astrea Bioseparations Introduces Nereus LentiHERO, a Fit-for-purpose Solution for Lentiviral Vector Purification

“We believe that AstreAdept will be a game-changer,” explained Astrea Bioseparations’ CEO Terry Pizzie. “Our approach was to rapidly develop and incorporate this material into the Nereus LentiHERO, a simple, fit-for-purpose device that radically transforms how lentivirus can be purified [in terms of speed, recovery, and efficiency].

At Pack Expo, Schreiner MediPharm to Debut Functional Labels Designed from More Sustainable Materials

Schreiner MediPharm advises he new label concepts are based on existing items in Schreiner MediPharm’s roster of functional labeling solutions.

Abraham Verghese MD, MACP has been named to Athos Therapeutics Board of Directors.

“I am honored to join the Athos Board of Directors,” said Dr. Verghese. “The company’s unique, objective and personalized approach to drug development is very exciting and has the potential to transform the lives of patients with various autoimmune diseases and cancer.”

“Dr. Verghese is a leading figure in medicine with a background in infectious disease and inflammation, and we are extremely pleased to have him on our Board of Directors,” said Dimitrios Iliopoulos, Ph.D. MBA, President & CEO.

“Dr. Verghese is a highly distinguished physician, humanist, administrator, and adviser. We look forward to having his insights and expertise guide our scientific and drug developments objectives,” said Allan Pantuck, MD, MS, FACS, Chairman & CMO.

Abraham Verghese MD is the Linda R. Meier and Joan F. Lane Provostial Professor, and Vice Chair of the Department of Medicine at Stanford University School of Medicine. His training is in infectious diseases and pulmonary medicine.

At Stanford, in addition to seeing inpatients and teaching medical students, he runs PRESENCE, a multidisciplinary project that studies the human experience of patients, physicians and caregivers. He is also a writer; his last book, Cutting for Stone, was an international bestseller.

His work has appeared in the New Yorker, Granta, the New York Times and elsewhere. He was elected to the National Academy of Medicine and to the American Academy of Arts and Sciences. He is a recipient of the National Humanities Medal at the White House from former President Obama.


Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine